Image provided by: University of Oregon Libraries; Eugene, OR
About Just out. (Portland, OR) 1983-2013 | View Entire Issue (Oct. 1, 1989)
Hired Hands Massage Co. “ M y lo v in g , s u p p o r t iv e a n d w a r m to u c h h a s a p r o f o u n d effect o n y o u r h e a lth a n d w e l l -b e i n g . ” John Clark, LMT 645-6826 By appointment only $30 per hour AZT and Interferon-alpha for KS Gay men with Kaposi’s sarcoma benefit from a combination of AZT and interferon- alpha, say doctors at the National Institutes of Health. This combination of drugs reduced the size of tumors for 11 out of 22 PWAs, and the amount of HIV decreased for eight out of 22 PWAs. However, this drug combination also increased the frequency of side effects. Doctors at the NIH recommend that PWAs with Kaposi’s sarcoma receive long-term therapy with AZT (100 mg every four hours) and interferon-alpha (5-10 million units). Reference: J. Kovacs and others. "Combined Zidovudine and Interferon-alpha 7 herapy in Patients with Kaposi Sarcoma and AIDS." Annals of Internal Medicine, August 15,1989, pp: 280-87. J ß t c m \\ * IP J»* . ■ i t ' 4 * é i « i n fit f 9 9 9 9 9 M ¿ ti r i a » . ** ?<, an T » »»tasi e * ' { * 1 1 custom-scented lotions end oils, be ith and skin care, u a v v l I t l o t soaps, cards, gift bags, wrap . . . a nd more 3 6 3 8 S E H a w th o rn e BfVd 2 3 6 - 7 9 7 6 « 7 1 0 N W 23r d Ave 248-9748 111 i SANDRA K. PINCHES, Ph.D. Counseling and Psychotherapy 1809 N.W. Johnson, Sie. 7 Portland, OR 97209 Specializing in issues of: (5°3) 227 7558 • Recovering Alcoholics • Lesbian & gay couples • Co-dependency • Intimacy & commitment You I I know it w hen you see i t Like love at first sight, ou'll know your new l ome when you see it. My job as a professional Realtor is to make the process of finding your home as easy as possible. You’ll have my support from start to finish, through the search, financing, and escrow. I'll listen to your dreams and your needs and put my knowledge, experience and resources to work. Then comes the fun part. lake sinking into a comfortable chair, you'll know the one for you by how good it feels. Gail me. I'll help you find your way home. Cathy Siemens Bridgetown Realty (5 0 3 )2 8 7 -9 3 7 0 (503) 238-0135(home ) just out ▼ 6 ▼ October 1989 BY J E F F R E Y ZURLINDEN Antibodies may speed infection Scientists question whether certain antibodies to HIV actually help the virus to infect new cells. These enhancing antibodies may allow HIV to enter white blood cells that have few of the usual entry sites for HIV. Enhancing antibodies may temporarily in crease the rate of infection of new cells by tenfold. Before vaccines can be tested, researchers plan to fully identify the effects of enhancing antibodies. Reference: D. Bolognesi. "Do Antibodies Enhance the Infection of Cells by HIV." Nature, August 10,1989, pp: 431-32. New testing begins for AIDS drug Immunoadhesin, a new drug to fight HIV, began testing last month. This new form of soluble r-CD4 combines the part of the T-cell • • • • • Crystals 8c Gems Ritual Accessories Incenses 8c Oils Astrology Computer Srvcs Lending Library that attaches to HIV with an antibody that activates killer cells to attack HIV. In total, 3040 people will receive this experimental drug. Scientists hope that immunoadhesin will find HIV-infected cells and activate the infected person’s immune system to kill HIV. These initial clinical trials will be conducted by the U.S. National Cancer Institute, New England Deaconess Hospital, San Francisco General Hospital, the University of Washington, and Stanford University. • Reference: C. Ezzell. "AIDS Closer to Becoming a Treatable D is e a s e Nature, August 24,1989, p: 581. New AZT studies Dr. Anthony Fauci announced in August that AZT benefits otherwise healthy people who are infected with HIV, but little was said about the studies that led to the recommendations. These recommendations are based on a two-year study of 3,200 people — one-third of whom received low doses of AZT (500 mg daily), one-third who received high doses of AZT (1,500 mg daily), and the remaining third who received placebo (no AZT). Among the people taking placebo, 38 progressed to AIDS or severe ARC. Only 17 who received low doses of AZT and 19 who received high doses of AZT progressed to AIDS or ARC. The researchers concluded that low doses of AZT (500 mg daily) delay the onset of ARC and AIDS among people with fewer than 500 helper T-cells. Although AZT can cause severe side effects in PWAs, only 3 percent of the healthy HIV-infected people in this study developed side effects. These people reported only mild side effects — usually limited to nausea. The study will continue to determine if people with more than 500 helper T-cells also benefit from AZT. Reference: J. Marx. "Wider Use of AIDS Drugs Advocated." Science, August 25,1989, % p: 811. Few cases of HIV-2 in United States So far the CDC has reported only six people in the United States who are infected with HIV-2, a close relative of HIV-1 that also leads to AIDS. All six people immigrated from Africa. HIV-2 is probably spread in the same way as HIV-1, and the CDC recommends the same precautions to prevent infection with either virus. Reference: CDC, "Update: HIV-2 Infection- US." MMWR, August 25,1989, pp: 572-80. CRONE MAGIC 249-0444 12-7 MON.-SAT. 1405 NE BROADWAY PORTLAND, OR 97232 M è È èèè